Skip to content
Menu

TD Cowen Maintains Buy on Twist Bioscience, Lowers Price Target to $137

Benzinga Newsdesk 2 days ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

TD Cowen analyst Brendan Smith maintains Twist Bioscience (NASDAQ:TWST) with a Buy and lowers the price target from $190 to $137.

TD Cowen analyst Brendan Smith maintains Twist Bioscience (NASDAQ:TWST) with a Buy and lowers the price target from $190 to $137.

Read at benzinga.com